BackGeneFerm Biotechnology , Ltd. Overview

GeneFerm Biotechnology , Ltd. Current Cash

GeneFerm Biotechnology , Ltd.'s current cash is $170M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$173.23M
↓ 37.11% YoYΔ $-102.22M vs prior year quarter

Peer trimmed avg / median

Loading

GeneFerm Biotechnology , Ltd. Current Cash History

Loading

GeneFerm Biotechnology , Ltd. vs. peers: Current Cash Comparison

Loading

GeneFerm Biotechnology , Ltd. Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GeneFerm Biotechnology , Ltd. (1796.TWO) FAQ

As of the most recent data (September 2026), 1796.TWO shows a current cash of $170M. That compares with $280M in the prior-year period — down 37.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 1796.TWO's current cash is now $170M (was $280M) — a 37.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether GeneFerm Biotechnology , Ltd. is outperforming or lagging.

Tracking 1796.TWO's current cash over time shows whether GeneFerm Biotechnology , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $170M That compares with $280M in the prior-year period — down 37.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has GeneFerm Biotechnology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $170M) with ownership activity and broader fundamentals.